Skip to content
  1. Home/
  2. Latest news/
  3. Caring & giving/
  4. How Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation are making a difference for military veterans
Johnson & Johnson Stephen Siller Tunnel to Towers Foundation Tunnel
Members of the military participate in the Tunnel to Towers 5K Run & Walk

How Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation are making a difference for military veterans

Members of the military participate in the Tunnel to Towers 5K Run & Walk

Support for our nation’s soldiers is part of Johnson & Johnson’s DNA.

In the 1800s, the company was integral to spreading the word about the importance of sterile care for wounds sustained on the battlefield, thanks to its innovations in surgical dressings and sutures. And during the Spanish-American War, Johnson & Johnson did something groundbreaking and continued to pay employees their salaries, and held their positions for them, while they served.

That legacy continues to this day, from policies that make it easier for service members on leave to transition back into their day-to-day lives to partnerships that give them the skills and resources they need to thrive.

Partnerships like the one between Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation, which was founded in 2001 to help military veterans and first responders and their families.

In honor of the 16th annual Tunnel to Towers 5K Run & Walk on September 24, we’re taking a look at how both organizations have joined forces to be there for service members over the past three years.

Tunnel to Towers infographic

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.